ClinicalTrials.Veeva

Menu

Gender, Obesity, C-Reactive Protein, and Oxidative Stress

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status

Completed

Conditions

Cardiovascular Disease

Treatments

Dietary Supplement: Vitamin E
Dietary Supplement: Vitamin C
Dietary Supplement: Placebo

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00079963
62378DK
R01DK062378 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This randomized placebo-controlled trial will test whether supplementing with vitamins C and E can lower markers of inflammation and oxidative stress in healthy adults. We will examine whether one antioxidant vitamin is more effective than another, and whether gender or body fat influence the treatment effects. We will also determine whether gender, body fat, or menopausal status are associated with baseline concentrations of inflammation and oxidative stress markers.

Full description

Participants will be given 1000 mg vitamin C or 800 IU vitamin E daily for 60 days.

Enrollment

396 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Nonsmoker and not passively exposed
  • Males and females 18 year and older
  • Able to take vitamin supplements
  • Able to take acetominophen instead of aspirin or NSAIDs during the study

Exclusion criteria

  • Pregnancy or lactation
  • History of ever smoking or passive smoke exposure in the last year
  • Active liver disease; history of HIV/AIDS, diabetes, kidney stones, hemochromatosis, or autoimmune diseases; heart disease, stroke, or cancer in the last 5 years
  • User of prescribed anti-inflammatory or lipid-lowering medications, oral contraceptives, hormone replacement therapy, or blood-thinning drugs
  • User of iron supplements or vitamin E at 600 IU per day or more
  • Consumption of more than 2 alcoholic beverages per day

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

396 participants in 3 patient groups, including a placebo group

X
Experimental group
Description:
Vitamin C
Treatment:
Dietary Supplement: Vitamin C
Y
Experimental group
Description:
Vitamin E
Treatment:
Dietary Supplement: Vitamin E
Z
Placebo Comparator group
Description:
Placebo
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems